Leaderna Therapeutics Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Leaderna Therapeutics Ltd. - overview
Established
2022
Location
Chengdu, Sichuan, China
Primary Industry
Biotechnology
About
Based in Chengdu, China and founded in 2022, Leaderna Therapeutics Ltd. provides synthetic oligonucleotide drug research and development for the biotechnology industry. The company operates a full chain platform covering target validation, lead compound screening, and formulation development. The Chairman and General Manager is Dr.
Jinqiao Wan. In March 2026, the company raised CNY 150 million in series A funding co-led by Tao Capital and Qishen Venture Capital. The company works with the healthcare sector to provide innovative therapies for chronic diseases. A team of researchers and scientists develops small nucleic acid drugs utilizing proprietary technology platforms such as NEATL (novel delivery and nucleic acid enhancement), LOCATED (lipid conjugated extrahepatic delivery), and DIRECT (single molecule dual target interference).
The company generates revenue from the research, development and commercialization of its small nucleic acid drugs. The company plans to use the series A funding to advance the clinical development of its core small nucleic acid product pipelines, optimize key technology platforms such as extrahepatic delivery, and further expand its pre-clinical product layout and core team.
Current Investors
CDH Investments, Panlin Capital, Sky 9 Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Leaderna Therapeutics Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | Leaderna Therapeutics | - | ||||||||
| Series A | Completed | Leaderna Therapeutics | - | ||||||||
| Unspecified Round | Completed | Leaderna Therapeutics | - | ||||||||
| Unspecified Round | Completed | Leaderna Therapeutics | - | ||||||||
| Unspecified Round | Completed | Leaderna Therapeutics | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.